India markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
126.68-0.62 (-0.49%)
At close: 4:00PM EDT
Sign in to post a message.
  • J
    JL Prestige
    $TMDI conversation
    TMDI up 586% YOY at current SP.... Market has gotten smoked which has caused a pullback in this over the past 3 months, but nothing has changed as #TMDI is in the best position since its inception... Licensing and development $40M deal with the LARGEST med device company in the world in #MDT... Flooded with cash... 160+ patents... Single port robot that fits perfectly as organic growth opportunity for MDT Pelvic division... 2 out of 4 milestones completed with 3rd in the imminent future hopefully this month... New site visit education center in research triangle Chapel Hill, NC... MDT corporate sitting on our board... Mazor was purchased after same development agreement was done with MDT.... Next leg up will be biggest breakout yet, and once we get to the $4 threshold, big money will come in... I am extremely bullish on TMDI in 2021... GLTA fellow longs!
  • P
    Patrick
    This is a fantastic re-opening stock. Much of the goods and services provided by MDT have been on the shelf collecting dust. This company is burning rubber out of the gate and is going to leap higher. I can't view it any other way.
  • B
    Bill mddb
    No news, not much volume. I assume it's profit taking. Q4 and YE 2021 report and outlook will be public soon. I'll be interested in ventilator production. The Puritan Bennet 980 top of the line unit should be doing well, along with the rest of MDT.
  • B
    Bill mddb
    Love to see the market strength for MDT and medical devices in general - Stryker is also at all time highs. Q4 ending this month shows an analyst est of $1.42 up from $.58 last year as C-19 dropped revenue 26% - it was down 13% the next Q -- Q1 of this year. The composite analyst estimate for FY 2022 is $5.72 -- and FY 22 starts in 10 days -- so at $129 that's a p/e of 22.6 on this years earnings -- doesn't look like an over extended valuation since there is a good chance MDT will beat the Q4 estimates and FY 22 as well.
  • X
    XRP589HodLr
    DUBLIN, April 12, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) granted de novo clearance for GI Genius™ intelligent endoscopy module in the United States. The GI Genius module is the first and only commercially available computer-aided detection (CADe) system using artificial intelligence (AI) to identify colorectal polyps. The module, compatible with any colonoscope video, provides physicians with a powerful new solution in the fight against colorectal cancer — the third most common form of cancer globally with 1.8 million new cases in 2018.1
  • B
    Bill mddb
    If the US corporate tax rate goes up 7% then MDT will see a base 7% increase on Taxable Income from the 53% of MDT revenue from the US. Since MDT has been running a 15% - 15.5% blended overall tax rate, so it will see approximately a 3.5% increase, maybe 3.6% to its overall tax rate driving it up to the 18.5% - 19% range. However, US tax based competitors will see their overall blended rates go up by 7%. The US is the only significant nation that allows a deduction from US tax for foreign tax paid but if less than the base rate then more tax is owed to the US -- if France taxes your French Taxable Income at 18% you then owe 10% to the IRS. The US has the highest corporate tax rate so it makes sense to do this. So, MDT's overall cash flows will take a hit but half the hit of many competitors leaving it with an overall tax rate of about 19% if the US goes back to the 28% level. That 9% difference is for a mature firm with taxable income around the world. Omar pushed for the COV inversion to Ireland. Now the Treasury Sect says she will push for a global minimum tax. I don't think that will happen because Ireland and many other countries would love to see big firms set up in their countries. What I think will happen is that new law will be passed which will make it very difficult if not impossible to invert. That what Sect Lew tried to do to sink the MDT/COV inversion. I am very glad the inversion is now 6 yrs old, I'll wager that Medtronic will be mentioned as a reason to pass new rules governing proposed inversions so more big fish don't get away. The 2015 inversion will allow the 9% of Taxable Income saved annually to be used for dividends and buybacks.
  • e
    etsub
    DUBLIN , March 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for its Harmony™ Transcatheter Pulmonary Valve (TPV), the first minimally invasive therapy created to treat patients with a specific type of congenital heart defect of the right ventricle (RV)
  • A
    Amazonia
    Any technicians know the next level of resistance?
  • B
    Bill mddb
    It was encouraging to see MDT up a penny in a 143 DOW drop day. The consensus is that MDT is nosing up from being crowded out of hospitals by C-19. The CFO was uncommonly clear about this quarter at the Cowen Conference, released yesterday:

    Karen Parkhill

    Josh, the good news on that is that we did start to see our average daily sales turn last week, which we think is really encouraging. And we think underlying was turning the prior way, but it was muddled by the tough weather issues that we had across the United States. But we saw a clear turn last week. And so things have really started to improve as we predicted. We do remain optimistic on the quarter. We've got an overwhelming decrease of COVID cases throughout the world. ICU and hospital capacity is improving, and the vaccine roll-up is picking up momentum.

    So we've also seen stronger sales of our capital equipment, especially toward the end of last summer that we noted on our quarterly call. And we think that's a leading indicator and a positive sign because customers believe procedure volumes are coming back. So despite the COVID uncertainty, we have lots of reasons to be confident in our fourth quarter.
  • S
    Sjors
    This stock is about to break out 🚀
  • J
    JL Prestige
    Mike Williams is an absolute joke! Big Mike how is #ASXC performing? You know nothing and have been a short here #TMDI since $.70 with same dumb talking points... never offer anything of actual substance. I am long and up very big... didn’t sell a single share at $3.46 because that is pennies from where this will be in the near future ... #MDT is the largest med device company in the world, and TMDI has a development agreement with them... it’s only a matter of time... GLTA buy and hold
  • J
    Justin
    $SENS conversation
    Senseonics reports earnings and provides strong guidance
    $SENS $MDT $DXCM $ABT
  • D
    DontSow
    UK NHS testing their cancer camera capsules on patients. If it goes well boom
  • X
    XRP589HodLr
    From Seeking Alpha just now

    Medtronic (NYSE:MDT): Q3 Non-GAAP EPS of $1.29 beats by $0.14; GAAP EPS of $0.94 beats by $0.22.
  • J
    JIII
    From 02/17
    Morgan Stanley Expects Medtronic, Inc. (MDT) To Miss Consenus Revenue

    a day ago

    He stated "Based on peer results and management commentary, we expect Medtronic to miss Cns revenues by ~50-250 bps given December-to-January resurgence (i.e., we expect a ~flat to -2% organic quarter), still positioning Medtronic toward the high-end of C4Q Device averages (see Exhibit 2 for peer 2-year stack analysis). Absolute results matter less, while evidence that Medtronic may be weathering resurgence better than peers matters more. We remain comfortable with the risk/reward into the quarter and continue to favor Medtronic as one of the best names in our coverage to play 2021 Device recovery."
  • s
    stocktargetadvisor
    $MDT
    Target Raised by SVB Leerink Market Perform USD 123 » USD 129
  • J
    James
    Anyone heard anything about buying Titan Medical?
  • B
    BrokeAF
    Does anyone have a solid argument as to whether MDT could be held liable (meaning a lawsuit) for the recalled stents? Thoughts?
  • T
    Timothy
    Why SENS NOW? This is very important statement from Founder and CEO of FibroGEN INC. A company 3 times bigger then Sense with MC of 5 billion dollars.

    “ I have to say I have been a long time believer in this Company and have been dumbfounded on why it has taken till now to finally be realized for its value. I am a Biomedical Scientist who helped to found FibroGen, Inc and I feel SENS has more to offer in the long run. Very important technology and an enormous market that needs this type of continuous monitoring. I was a speaker at a Juvenile Diabetes Medical Meeting in Dallas Tx in 1981 and the physicians were praying for something like the SENS technology to help Diabetics become healthier and safer. Now it is here and with future work to couple the sensors with a pump to deliver the correct amount of insulin you will have the dream that has been the Holy Grail for Diabetic Therapy for 45 years. I am happy to have found such a great company and I think they should go to $100 and beyond.
  • e
    etsub